2.
醇175 mg/m2及200 mg/m2组患者临床疗效、疾病进展时间及生存期比较
Comparison of response rate, median time to progression, median survival time and survival rates between paclitaxel (175 mg/m2) and paclitaxel (200 mg/m2) groups
| Item | Paclitaxel 175 mg/m2 group (n =42) | Paclitaxel 200 mg/m2 group (n =21) | P |
| Response rate Complete Response (n) | 0 | 0 | |
| Partial Response (n) | 12 (28.57%) | 7 (33.33%) | |
| Stable disease (n) | 21 (50.00%) | 9 (42.86%) | |
| Progression of disease (n) | 9 (21.43%) | 5 (23.81%) | |
| Objective response rate (%) | 12 (28.57%) | 7 (33.33%) | 0.698 |
| Median time to progression (month) | 6.7 | 7.0 | 0.561 |
| Median survival time (month) | 18.7 | 19.0 | 0.255 |
| 1-year survival rate (%) | 61.9% | 66.7% | 0.711 |
| 2-year survival rate (%) | 31.0% | 33.3% | 0.852 |